(Q34307614)

1 August 2017

1 reference

title

Calcium channel blockers in the management of preterm labor and hypertension in pregnancy (English)

1 reference

1 August 2017

0 references

1 reference

1 reference

Papatsonis DN

1

1 reference

1 August 2017

Lok CA

2

1 reference

1 August 2017

Bos JM

3

1 reference

1 August 2017

Geijn HP

4

1 reference

1 August 2017

Dekker GA

5

1 reference

1 August 2017

publication date

1 August 2001

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

1 August 2017

published in

1 reference

1 August 2017

volume

97

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

122-140

1 reference

Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Calcium-antagonist drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The use of calcium channel blockers in obstetrics and gynecology; a review

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Neonatal effects of nifedipine and ritodrine for preterm labor.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Biochemistry and pharmacology of the myometrium and labor: regulation at the cellular and molecular levels

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Current understanding of pharmacologic mechanisms in the prevention of preterm birth

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Myometrial desensitization after ritodrine infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Identification of P450 enzymes involved in metabolism of verapamil in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Pharmacologic treatment of preterm labor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Calcium channel blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Clinical pharmacokinetics of calcium antagonists. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Individualization of calcium entry-blocker dosage for systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Pharmacokinetics of calcium antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine pharmacokinetics during preterm labor tocolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine: kinetics and dynamics in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine and its indications in obstetrics and gynecology

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Clinical pharmacokinetics of vasodilators. Part II.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Pharmacological aspects of calcium channel blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine: effects on fetal and maternal hemodynamics in pregnant sheep.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Infants of mothers treated with ethanol for premature labor.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Hyperphalangeal bones induced in rat pups by maternal treatment with nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Identical phalangeal defects induced by phenytoin and nifedipine suggest fetal hypoxia and vascular disruption behind phenytoin teratogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The effects of nifedipine on pregnancy outcome and morphology of the placenta, uterus, and cervix during late pregnancy in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Deactivation of the uterus during normal and premature labor by the calcium antagonist nicardipine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Tocolytic and hemodynamic effects of nifedipine in the ewe

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The effect of a calcium channel blocker (nifedipine) on uterine blood flow in the pregnant goat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques: fetal plasma concentrations and cardiorespiratory changes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine does not adversely affect uteroplacental blood flow in the hypertensive term-pregnant rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Ovine fetal cardiorespiratory response to nicardipine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Fetal vascular responses to maternal nicardipine administration in the hypertensive ewe.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Effects of nifedipine on placental blood flow, placental weight and fetal weight in normotensive and spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Effect of nifedipine on fetal and maternal hemodynamics and blood gases in the pregnant ewe

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Cardiovascular and metabolic effects associated with nifedipine and ritodrine tocolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The effect of acute and chronic antihypertensive therapy on maternal and fetoplacental Doppler velocimetry

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Evaluation of the pharmacodynamics and pharmacokinetics of ritodrine when administered as a loading dose. On establishing a potentially useful drug administration regimen in cases of fetal distress.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Adverse Reactions to Calcium Antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Treatment of normotensive and hypertensive patients with preterm labor using oral nifedipine, a calcium antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Hepatotoxicity with the administration of nifedipine for treatment of preterm labor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Doppler assessment of the fetal and uteroplacental circulation during nifedipine therapy for preterm labor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The effect of nifedipine therapy on fetal and placental Doppler waveforms in preeclampsia remote from term.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Single dose of nifedipine in normotensive pregnancy: nifedipine concentrations, hemodynamic responses, and uterine and fetal flow velocity waveforms

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Effect of nifedipine on Doppler flow velocity waveforms in severe pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Evaluation of calcium-antagonist (Nifedipine) in the treatment of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Effects of nifedipine on umbilical artery velocity waveforms in healthy human fetuses

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine administered in pregnancy: effect on the development of children at 18 months

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The use of a calcium antagonist (nifedipine) to suppress preterm labour

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

A national survey on preterm labor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Maternal complications of parenteral beta-sympathomimetic therapy for premature labor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Beta-adrenergic agonists for preterm labor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Treatment of preterm labor with the beta-adrenergic agonist ritodrine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine for treatment of preterm labor: a historic prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Effect of nifedipine on fetal heart rate in the treatment of severe pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Treatment of severe pregnancy-associated hypertension with the calcium antagonist nifedipine.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

A randomized comparison of nifedipine and ritodrine for suppression of preterm labor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine versus ritodrine for suppression of preterm labour

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Comparison of Nifedipine and Ritodrine for the Treatment of Preterm Labor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Neonatal periventricular-intraventricular hemorrhage after maternal beta-sympathomimetic tocolysis. The March of Dimes Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Fetal and neonatal cardiovascular complications from beta-sympathomimetic therapy for tocolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Use of calcium channel blockers and breast carcinoma risk in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Calcium-channel blockade and incidence of cancer in aged populations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Do calcium channel blockers increase the risk of cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The risk of myocardial infarction associated with antihypertensive drug therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Cancer risk in users of calcium channel blockers.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Calcium Channel Blockers and the Risk of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Cancer risk of hypertensive patients taking calcium antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Calcium-channel blockers and risk of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Calcium channel blockers and cancer: is there preclinical evidence for an association?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Effects of calcium channel blockers on cellular apoptosis: implications for carcinogenic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Cancer risk and mortality in users of calcium channel blockers. A cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

New perspectives for the effective treatment of preterm labor.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Preterm labor: its diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The epidemiology of preterm birth

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

A multicenter study of preterm birth weight and gestational age-specific neonatal mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Treatment of preterm labor with the oxytocin antagonist atosiban

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Relaxant effects of nifedipine on isolated, human myometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Comparison of the effects of nicardipine and nifedipine on isolated human myometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

A comparison of several calcium antagonists on uterine, vascular and cardiac muscles from the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The effects of aminophylline and nifedipine on contractility of isolated pregnant human myometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Evaluation of drugs for arrest of premature labor in a new animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Effects of nifedipine on myometrial activity and lower abdominal pain in women with primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Treatment of premature labor with the calcium antagonist nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Effects of nifedipine on spontaneous and methylergometrine-induced activity post partum

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Effects of nifedipine on oxytocin- and prostaglandin F2 alpha -induced activity in the postpartum uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Clinical comparison of oral nifedipine and subcutaneous terbutaline for initial tocolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Diltiazem for maintenance tocolysis of preterm labor: comparison to nifedipine in a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nicardipine versus salbutamol in the treatment of premature labor. A prospective randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine as a safe and effective tocolytic agent in the treatment of preterm labor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Does magnesium sulfate treat eclamptic convulsions?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Management of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The pharmacological management of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Drug management of hypertensive disorders of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Fortnightly review: management of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The haemodynamic effects of ketanserin versus dihydralazine in severe early-onset hypertension in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Acute effects of nitrendipine in pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Oral nifedipine therapy in the management of severe preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Analysis of the risks associated with calcium channel blockade: implications for the obstetrician-gynecologist

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The oxygen consumption/oxygen delivery curve in severe preeclampsia: evidence for a fixed oxygen extraction state

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Oxygen delivery and consumption in critically ill pregnant patients: association with ophthalmic artery diastolic velocity.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Persistent cerebrovascular changes in postpartum preeclamptic women: a Doppler evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The effect of nifedipine and methyldopa on maternal cerebral circulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nimodipine in the management of preeclampsia: maternal and fetal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Effect of nifedipine on renal function in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

The use of nifedipine during the postpartum period in patients with severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine and Platelets in Preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine treatment in preeclampsia reverts the increased erythrocyte aggregation to normal

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Developments in CTG analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900548-0

7 January 2021

10.1016/S0301-2115(00)00548-0

Identifiers

DOI

1 reference

1 August 2017

1 reference